Comparison of surgical outcomes between thoracoscopic anatomical sublobar resection including and excluding subsegmentectomy

Objectives Despite the ubiquitous utilization of anatomical sublobar resection for malignant lung tumors, the effectiveness and feasibility of subsegmentectomy remains unclear. This study therefore compared the perioperative outcomes between anatomical sublobar resection including (IS) and excluding...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:General thoracic and cardiovascular surgery 2021-05, Vol.69 (5), p.850-858
Hauptverfasser: Matsui, Takuya, Takahashi, Yusuke, Shirai, Suguru, Nakanishi, Keita, Nakada, Takeo, Sakakura, Noriaki, Haneda, Hiroshi, Okuda, Katsuhiro, Nakanishi, Ryoichi, Kuroda, Hiroaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Despite the ubiquitous utilization of anatomical sublobar resection for malignant lung tumors, the effectiveness and feasibility of subsegmentectomy remains unclear. This study therefore compared the perioperative outcomes between anatomical sublobar resection including (IS) and excluding (ES) subsegmentectomy. Methods Patients who had undergone anatomical sublobar resection at our institution from January 2013 to March 2019 were retrospectively reviewed. Clinicopathologic characteristics and perioperative outcomes of the IS group ( n  = 58) were then analyzed the compared to those of the ES group ( n  = 203). Results No statistically significant differences in age, sex, comorbidities, tumor location, preoperative pulmonary function, or tumor size on imaging were found between both groups. The IS group had significantly higher preoperative computed tomography-guided marking rates (40% vs. 18%; p   0.99), intraoperative complications (7% vs. 10%; p  = 0.61), and postoperative complications (5% vs. 8%; p  = 0.58). After propensity score matching, the IS group experienced significantly lesser blood loss than the ES group (5 mL, IQR: 1–10 vs. 5 mL, IQR: 5–20; p  = 0.03). Both groups experienced no local recurrence and demonstrated similar postoperative pulmonary functions after surgery. Conclusions IS may be a feasible and acceptable therapeutic option for malignant lung tumors. Nonetheless, future investigations are required to further validate the current findings.
ISSN:1863-6705
1863-6713
DOI:10.1007/s11748-020-01556-3